Additionally, BRD7 inhibits METTL3-mediated HR repair and radioresistance in NPC cells by prohibiting the recruitment of BRCA1 and RAD51 to sites of IR-induced DNA damage (Figure 8F). The gene discussed is METTL3; the disease is nasopharyngeal carcinoma.